In 52% of NPM1 mutated MDS/AML an immature monocytic population was detected, which was positive for HLA-DR, variably positive for CD4, CD15, brightly positive for CD33 and CD64, and negative for CD13, CD14, CD16, CD34, or CD117 (174). This evidence concerns the gene NPM1 and myelodysplastic syndrome.